JP2011526153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526153A5 JP2011526153A5 JP2011516724A JP2011516724A JP2011526153A5 JP 2011526153 A5 JP2011526153 A5 JP 2011526153A5 JP 2011516724 A JP2011516724 A JP 2011516724A JP 2011516724 A JP2011516724 A JP 2011516724A JP 2011526153 A5 JP2011526153 A5 JP 2011526153A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- regulation
- glycyl
- trna synthetase
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 48
- 229920001184 polypeptide Polymers 0.000 claims description 47
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 23
- 108010051724 Glycine-tRNA Ligase Proteins 0.000 claims description 22
- 102000019220 Glycyl-tRNA synthetases Human genes 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 14
- 230000033228 biological regulation Effects 0.000 claims description 12
- 230000005754 cellular signaling Effects 0.000 claims description 12
- 230000001404 mediated effect Effects 0.000 claims description 12
- 108091033319 polynucleotide Proteins 0.000 claims description 11
- 102000040430 polynucleotide Human genes 0.000 claims description 11
- 239000002157 polynucleotide Substances 0.000 claims description 11
- 230000004071 biological effect Effects 0.000 claims description 8
- 230000009134 cell regulation Effects 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 101001072736 Homo sapiens Glycine-tRNA ligase Proteins 0.000 claims description 6
- -1 IL1-β Proteins 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 6
- 102000036639 antigens Human genes 0.000 claims description 6
- 108091007433 antigens Proteins 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 6
- 108020001507 fusion proteins Proteins 0.000 claims description 6
- 102000037865 fusion proteins Human genes 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000012636 effector Substances 0.000 claims description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical group OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 4
- 101001027327 Bos taurus Growth-regulated protein homolog alpha Proteins 0.000 claims description 4
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 4
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 4
- 102000001326 Chemokine CCL4 Human genes 0.000 claims description 4
- 108010055165 Chemokine CCL4 Proteins 0.000 claims description 4
- 102000016950 Chemokine CXCL1 Human genes 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 4
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 4
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 4
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 claims description 4
- 108090000174 Interleukin-10 Proteins 0.000 claims description 4
- 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 claims description 4
- 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 claims description 4
- 108090001005 Interleukin-6 Proteins 0.000 claims description 4
- 108090001007 Interleukin-8 Proteins 0.000 claims description 4
- 101150018665 MAPK3 gene Proteins 0.000 claims description 4
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 4
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 claims description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 230000016396 cytokine production Effects 0.000 claims description 4
- 102000009634 interleukin-1 receptor antagonist activity proteins Human genes 0.000 claims description 4
- 108040001669 interleukin-1 receptor antagonist activity proteins Proteins 0.000 claims description 4
- 230000025915 regulation of apoptotic process Effects 0.000 claims description 4
- 230000007980 regulation of cell activation Effects 0.000 claims description 4
- 230000012760 regulation of cell migration Effects 0.000 claims description 4
- 230000024833 regulation of cytokine production Effects 0.000 claims description 4
- 230000011664 signaling Effects 0.000 claims description 4
- 102100036589 Glycine-tRNA ligase Human genes 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 230000025053 regulation of cell proliferation Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 208000023275 Autoimmune disease Diseases 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 208000012902 Nervous system disease Diseases 0.000 claims description 2
- 208000025966 Neurological disease Diseases 0.000 claims description 2
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 230000033115 angiogenesis Effects 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 208000030159 metabolic disease Diseases 0.000 claims description 2
- 230000001613 neoplastic effect Effects 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 description 3
- 239000000556 agonist Substances 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7609808P | 2008-06-26 | 2008-06-26 | |
| US61/076,098 | 2008-06-26 | ||
| US9554808P | 2008-09-09 | 2008-09-09 | |
| US61/095,548 | 2008-09-09 | ||
| PCT/US2009/048915 WO2009158649A1 (en) | 2008-06-26 | 2009-06-26 | Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015042000A Division JP6025889B2 (ja) | 2008-06-26 | 2015-03-04 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011526153A JP2011526153A (ja) | 2011-10-06 |
| JP2011526153A5 true JP2011526153A5 (enExample) | 2012-08-02 |
| JP5756751B2 JP5756751B2 (ja) | 2015-07-29 |
Family
ID=41136705
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011516724A Active JP5756751B2 (ja) | 2008-06-26 | 2009-06-26 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
| JP2015042000A Active JP6025889B2 (ja) | 2008-06-26 | 2015-03-04 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
| JP2016104002A Withdrawn JP2016154561A (ja) | 2008-06-26 | 2016-05-25 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015042000A Active JP6025889B2 (ja) | 2008-06-26 | 2015-03-04 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
| JP2016104002A Withdrawn JP2016154561A (ja) | 2008-06-26 | 2016-05-25 | 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US8404471B2 (enExample) |
| EP (2) | EP3176261A1 (enExample) |
| JP (3) | JP5756751B2 (enExample) |
| CN (2) | CN102159708B (enExample) |
| WO (1) | WO2009158649A1 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5771142B2 (ja) * | 2008-06-11 | 2015-08-26 | エータイアー ファーマ， インコーポレイテッド | チロシル−ｔＲＮＡシンテターゼポリペプチドの血小板新生活性 |
| US8404471B2 (en) | 2008-06-26 | 2013-03-26 | Atyr Pharma, Inc. | Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
| US8901081B2 (en) * | 2008-10-10 | 2014-12-02 | Snu R&Db Foundation | Uses of GRS proteins or fragments thereof |
| WO2010099477A2 (en) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
| US8404242B2 (en) | 2009-03-16 | 2013-03-26 | Atyr Pharma, Inc. | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities |
| US20100310576A1 (en) * | 2009-03-31 | 2010-12-09 | Adams Ryan A | COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
| WO2011072266A2 (en) * | 2009-12-11 | 2011-06-16 | Atyr Pharma, Inc. | Aminoacyl trna synthetases for modulating hematopoiesis |
| US9127268B2 (en) | 2009-12-11 | 2015-09-08 | Atyr Pharma, Inc. | Aminoacyl tRNA synthetases for modulating inflammation |
| JP6066900B2 (ja) | 2010-04-26 | 2017-01-25 | エータイアー ファーマ， インコーポレイテッド | システイニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| ES2638311T3 (es) * | 2010-04-27 | 2017-10-19 | Atyr Pharma, Inc. | Descubrimiento innovador de composiciones terapéuticas, diagnósticas y de anticuerpos relacionadas con fragmentos de proteína de treonil ARNt sintetasas |
| US8961960B2 (en) | 2010-04-27 | 2015-02-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| JP6008837B2 (ja) | 2010-04-28 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | アラニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| US8986680B2 (en) | 2010-04-29 | 2015-03-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases |
| WO2011139907A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| JP6008841B2 (ja) | 2010-05-03 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | メチオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| US8961961B2 (en) | 2010-05-03 | 2015-02-24 | a Tyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
| AU2011248227B2 (en) | 2010-05-03 | 2016-12-01 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| CA2797799C (en) | 2010-05-03 | 2020-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| EP2566499B1 (en) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| JP6008843B2 (ja) | 2010-05-04 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | グルタミル−プロリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| EP2568996B1 (en) * | 2010-05-14 | 2017-10-04 | aTyr Pharma, Inc. | Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| AU2011256366C1 (en) | 2010-05-17 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| EP2571513B1 (en) * | 2010-05-17 | 2016-09-07 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| CN103096913B (zh) | 2010-05-27 | 2017-07-18 | Atyr 医药公司 | 与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| CA2800281C (en) | 2010-06-01 | 2021-01-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| CA2804278C (en) * | 2010-07-12 | 2021-07-13 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| CA2804416C (en) * | 2010-07-12 | 2020-04-28 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| KR20130102534A (ko) | 2010-07-12 | 2013-09-17 | 에이티와이알 파마, 인코포레이티드 | 히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견 |
| US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| JP5964304B2 (ja) * | 2010-08-25 | 2016-08-03 | エータイアー ファーマ， インコーポレイテッド | チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| EP2624857B1 (en) | 2010-10-06 | 2017-08-02 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases |
| WO2012158945A2 (en) * | 2011-05-19 | 2012-11-22 | The Scripps Research Institute | Compositions and methods for treating charcot-marie-tooth diseases and related neuronal diseases |
| US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
| KR101398079B1 (ko) * | 2011-10-10 | 2014-05-27 | 재단법인 의약바이오컨버젼스연구단 | 글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법 |
| WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
| US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
| CA2858613A1 (en) | 2011-12-29 | 2013-08-08 | Atyr Pharma, Inc. | Aspartyl-trna synthetase-fc conjugates |
| JP6170077B2 (ja) | 2012-02-16 | 2017-07-26 | エータイアー ファーマ， インコーポレイテッド | 自己免疫および炎症疾患を処置するためのヒスチジルｔＲＮＡ合成酵素 |
| ES2708565T3 (es) | 2013-03-15 | 2019-04-10 | Atyr Pharma Inc | Conjugados de Fc-histidil-ARNt sintetasa |
| SG11201601263WA (en) * | 2013-09-12 | 2016-03-30 | Lanzatech New Zealand Ltd | Recombinant microorganisms and methods of use thereof |
| KR101771068B1 (ko) * | 2015-07-14 | 2017-08-24 | 재단법인 의약바이오컨버젼스연구단 | 케모카인 활성을 가지는 신규한 폴리펩타이드 |
| WO2017066459A1 (en) * | 2015-10-14 | 2017-04-20 | The Scripps Research Institute | INHIBITION OF NEDDYLATION USING GLYCYL-tRNA SYNTHETASE INHIBITORS |
| EP3612215B1 (en) | 2017-04-20 | 2024-08-28 | aTyr Pharma, Inc. | Compositions for treating lung inflammation |
| KR102167755B1 (ko) * | 2018-05-23 | 2020-10-19 | 주식회사 큐어바이오 | 단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도 |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4489710A (en) | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4625014A (en) | 1984-07-10 | 1986-11-25 | Dana-Farber Cancer Institute, Inc. | Cell-delivery agent |
| US4542225A (en) | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
| US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
| DE69312487T2 (de) | 1992-05-18 | 1997-11-27 | Minnesota Mining & Mfg | Einrichtung zur transmucosalen wirkstoffabgabe |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| GB9601067D0 (en) | 1996-01-19 | 1996-03-20 | Smithkline Beecham Plc | Novel compounds |
| WO1997026354A1 (en) | 1996-01-19 | 1997-07-24 | Smithkline Beecham Plc | HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| WO1997026349A1 (en) | 1996-01-19 | 1997-07-24 | Smithkline Beecham Plc | LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| GB9607993D0 (en) | 1996-04-18 | 1996-06-19 | Smithkline Beecham Plc | Novel compounds |
| US5795758A (en) | 1997-04-18 | 1998-08-18 | Smithkline Beecham Corporation | DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae |
| US5882892A (en) | 1997-07-23 | 1999-03-16 | Smithkline Beecham Corporation | Asps |
| US5858720A (en) | 1997-07-23 | 1999-01-12 | Smithkline Beecham Corporation | Hiss |
| US6428960B1 (en) * | 1998-03-04 | 2002-08-06 | Onyx Pharmaceuticals, Inc. | Selection method for producing recombinant baculovirus |
| EP1060258A1 (en) * | 1998-03-04 | 2000-12-20 | Onyx Pharmaceuticals, Inc. | Baculovirus expression system and method for high throughput expression of genetic material |
| US6548060B1 (en) * | 1999-11-18 | 2003-04-15 | Sunghoon Kim | Anti-apoptotic use of human glutaminyl-tRNA synthetase with two consecutive pro-apoptotic mediators |
| AU2001245899B2 (en) * | 2000-03-31 | 2006-06-15 | The Scripps Research Institute | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| US7144984B2 (en) * | 2000-03-31 | 2006-12-05 | The Scripps Research Institute | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| US7273844B2 (en) * | 2000-03-31 | 2007-09-25 | The Scripps Research Institute | Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| CN1322818A (zh) | 2000-05-09 | 2001-11-21 | 上海博德基因开发有限公司 | 一种新的多肽——人II类氨酰基－tRNA合成酶10和编码这种多肽的多核苷酸 |
| US20040181830A1 (en) * | 2001-05-07 | 2004-09-16 | Kovalic David K. | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| JP2004510407A (ja) | 2000-05-25 | 2004-04-08 | インサイト・ゲノミックス・インコーポレイテッド | アミノアシルｔＲＮＡ合成酵素 |
| CN1341727A (zh) | 2000-09-07 | 2002-03-27 | 上海博德基因开发有限公司 | 一种新的多肽——甲硫氨酰tRNA合成酶35.09和编码这种多肽的多核苷酸 |
| CN1341725A (zh) | 2000-09-07 | 2002-03-27 | 上海博德基因开发有限公司 | 一种新的多肽——人苏氨酰－tRNA合成酶48.73和编码这种多肽的多核苷酸 |
| CN1352242A (zh) | 2000-11-02 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人谷氨酰tRNA合成酶12.65和编码这种多肽的多核苷酸 |
| CN1352252A (zh) | 2000-11-06 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人II类氨酰基－tRNA合成酶11.77和编码这种多肽的多核苷酸 |
| JP2004537270A (ja) | 2000-12-15 | 2004-12-16 | インサイト・ゲノミックス・インコーポレイテッド | アミノアシルｔＲＮＡ合成酵素 |
| JP2004524021A (ja) | 2001-01-12 | 2004-08-12 | エクセリクシス・インコーポレイテッド | ＨｉｓＲＳをターゲッティングすることによるＳＲＥＢＰ経路の調節 |
| US6743619B1 (en) * | 2001-01-30 | 2004-06-01 | Nuvelo | Nucleic acids and polypeptides |
| BR0207449A (pt) | 2001-02-23 | 2004-04-06 | Scripps Research Inst | Polipeptìdeos derivados de triptofanil-trna sintetase úteis para regulação da angiogênese |
| US6903189B2 (en) * | 2001-03-21 | 2005-06-07 | The Scripps Research Institute | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| EP1490483B1 (en) | 2001-04-19 | 2015-06-03 | The Scripps Research Institute | In vivo incorporation of unnatural amino acids |
| US20030215827A1 (en) * | 2001-05-22 | 2003-11-20 | Henry Yue | Aminoacyl trna synthetases |
| US20040018505A1 (en) * | 2001-06-29 | 2004-01-29 | Lee Ernestine A. | Aminoacyl trna synthetases |
| WO2003009813A2 (en) | 2001-07-26 | 2003-02-06 | Novartis Ag | Methods of treating neuropilin-mediated diseases |
| US20040048290A1 (en) * | 2001-12-13 | 2004-03-11 | Lee Ernestine A | Aminoacyl trna synthetases |
| US20040101879A1 (en) * | 2002-01-11 | 2004-05-27 | Cynthia Seidel-Dugan | Srebp pathway modulation through targeting hisrs |
| AU2003225910A1 (en) | 2002-03-20 | 2003-10-08 | Johns Hopkins University | Raav vector compositions and methods for the treatment of choroidal neovascularization |
| AU2003234600A1 (en) | 2002-05-13 | 2003-11-11 | Rigel Pharmaceuticals, Inc. | tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS |
| EP1369482A1 (en) * | 2002-06-07 | 2003-12-10 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Target genes for the diagnosis and treatment of cancer |
| KR100575251B1 (ko) * | 2003-03-03 | 2006-05-02 | 재단법인서울대학교산학협력재단 | ｐ38／ＪＴＶ－1을 유효성분으로 하는 암 치료용 약학적조성물 및 암 치료용 약학적 조성물의 스크리닝 방법 |
| KR100599454B1 (ko) * | 2004-04-27 | 2006-07-12 | 재단법인서울대학교산학협력재단 | 종양 억제자로 작용하는 ａｉｍ3의 신규 용도 |
| PL1765362T3 (pl) * | 2004-06-04 | 2012-08-31 | Scripps Research Inst | Kompozycje i sposoby do leczenia chorób związanych z neowaskularyzacją |
| US20060024288A1 (en) * | 2004-08-02 | 2006-02-02 | Pfizer Inc. | tRNA synthetase fragments |
| US20060079673A1 (en) | 2004-08-02 | 2006-04-13 | Paul Glidden | Polynucleotides encoding tRNA synthetase fragments and uses thereof |
| US8282921B2 (en) * | 2004-08-02 | 2012-10-09 | Paul Glidden | tRNA synthetase fragments |
| US20060078553A1 (en) * | 2004-10-07 | 2006-04-13 | Paul Glidden | Diverse multi-unit complexes including a tRNA synthetase fragment |
| US7459529B2 (en) | 2004-11-24 | 2008-12-02 | Seoul National University Industry Foundation | AIMP2-DX2 and its uses |
| US8003780B2 (en) * | 2004-11-24 | 2011-08-23 | Neomics Co., Ltd. | AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2 |
| US7514229B2 (en) * | 2005-09-29 | 2009-04-07 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for diagnosing and evaluating treatment of blood disorders |
| AU2006320361B2 (en) | 2005-12-02 | 2012-10-25 | The Scripps Research Institute | Angiogenic tyrosyl tRNA synthetase compositions and methods |
| WO2008007818A1 (en) | 2006-07-13 | 2008-01-17 | Seoul National University Industry Foundation | Novel use of aimp1 for controlling glucose level |
| US20100120627A1 (en) * | 2006-08-02 | 2010-05-13 | Abdelmajid Belouchi | Genemap of the human genes associated with psoriasis |
| JP2010525362A (ja) | 2007-04-27 | 2010-07-22 | アイマジーン カンパニー リミテッド | 免疫調節剤のスクリーニング方法 |
| CA2718153A1 (en) | 2008-03-11 | 2009-09-17 | University Of North Carolina At Chapel Hill | Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| JP5771142B2 (ja) * | 2008-06-11 | 2015-08-26 | エータイアー ファーマ， インコーポレイテッド | チロシル−ｔＲＮＡシンテターゼポリペプチドの血小板新生活性 |
| US8404471B2 (en) | 2008-06-26 | 2013-03-26 | Atyr Pharma, Inc. | Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
| CN102124104A (zh) * | 2008-08-18 | 2011-07-13 | 财团法人首尔大学校产学协力财团 | 通过调节赖氨酰tRNA合成酶的细胞水平控制癌症转移或癌细胞移动的方法 |
| KR101067817B1 (ko) * | 2008-10-10 | 2011-09-27 | 서울대학교산학협력단 | Ａｉｍｐ1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물 |
| US8901081B2 (en) * | 2008-10-10 | 2014-12-02 | Snu R&Db Foundation | Uses of GRS proteins or fragments thereof |
| KR101067815B1 (ko) * | 2009-02-05 | 2011-09-27 | 서울대학교산학협력단 | 제1형 당뇨병의 신규한 진단 마커 |
| US20120058133A1 (en) * | 2009-02-19 | 2012-03-08 | President And Fellows Of Harvard College | Inhibition of trna synthetases and therapeutic applications thereof |
| WO2010099477A2 (en) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
| US8404242B2 (en) * | 2009-03-16 | 2013-03-26 | Atyr Pharma, Inc. | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities |
| US20100310576A1 (en) * | 2009-03-31 | 2010-12-09 | Adams Ryan A | COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| US9127268B2 (en) | 2009-12-11 | 2015-09-08 | Atyr Pharma, Inc. | Aminoacyl tRNA synthetases for modulating inflammation |
| WO2011072266A2 (en) | 2009-12-11 | 2011-06-16 | Atyr Pharma, Inc. | Aminoacyl trna synthetases for modulating hematopoiesis |
| US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
| WO2011097031A2 (en) | 2010-02-04 | 2011-08-11 | The Scripps Research Institute | Monomeric forms of human aminoacyl-trna synthetases having non-canonical biological activities |
| US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| CA2804416C (en) | 2010-07-12 | 2020-04-28 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
-
2009
- 2009-06-26 US US12/492,925 patent/US8404471B2/en active Active
- 2009-06-26 WO PCT/US2009/048915 patent/WO2009158649A1/en not_active Ceased
- 2009-06-26 CN CN200980132761.XA patent/CN102159708B/zh active Active
- 2009-06-26 JP JP2011516724A patent/JP5756751B2/ja active Active
- 2009-06-26 EP EP16183399.1A patent/EP3176261A1/en not_active Withdrawn
- 2009-06-26 CN CN201610829018.1A patent/CN106434576A/zh active Pending
- 2009-06-26 EP EP09771180A patent/EP2310498A1/en not_active Withdrawn
-
2013
- 2013-01-29 US US13/753,272 patent/US8747840B2/en active Active
-
2014
- 2014-04-25 US US14/262,247 patent/US9157076B2/en active Active
-
2015
- 2015-03-04 JP JP2015042000A patent/JP6025889B2/ja active Active
- 2015-09-03 US US14/844,666 patent/US9585946B2/en active Active
-
2016
- 2016-05-25 JP JP2016104002A patent/JP2016154561A/ja not_active Withdrawn
-
2017
- 2017-01-25 US US15/415,328 patent/US20170296635A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526153A5 (enExample) | ||
| JP2012520681A5 (enExample) | ||
| CN105073770B (zh) | 链霉亲和素突变蛋白及其使用方法 | |
| KR102567902B1 (ko) | 변형된 클리바아제, 이의 용도 및 관련 키트 | |
| JP2022065157A (ja) | 核酸エンコーディングを使用した巨大分子解析 | |
| US20200348307A1 (en) | Methods and compositions for polypeptide analysis | |
| CN112272703A (zh) | 采用核酸编码和/或标签进行分析的试剂盒 | |
| Kuo et al. | Exploiting the interactions between poly-histidine fusion tags and immobilized metal ions | |
| Zhao et al. | Recombinant production of medium-to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag | |
| AU2014314214B2 (en) | Binding polypeptides having a mutated scaffold | |
| JP2005517422A (ja) | 代替抗体ならびにその調製方法および使用 | |
| KR20130086386A (ko) | 생합성적으로 생성된 피롤린-카르복시-리신, 및 피롤린-카르복시-리신 및 피롤리신 잔기의 화학적 유도체화를 통한 부위 특이적 단백질 변형 | |
| Mooney et al. | Purification of a recombinant human growth hormone by an integrated IMAC procedure | |
| JP2019535321A5 (enExample) | ||
| Böhm et al. | Novel insights into structure and function of factor XIIIa-inhibitor tridegin | |
| CN114127281B (zh) | 邻近相互作用分析 | |
| KR20220012263A (ko) | 항체의 도메인-특이적 전하 변이체의 특징규명 | |
| WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
| JP7418412B2 (ja) | タンパク質の定性分析 | |
| Haque et al. | Identification of potent 11mer glucagon-like peptide-1 receptor agonist peptides with novel C-terminal amino acids: homohomophenylalanine analogs | |
| CN116685725A (zh) | 顺序编码方法和相关试剂盒 | |
| CA3127326A1 (en) | Methods and compositions of accelerating reactions for polypeptide analysis and related uses | |
| Zhang et al. | Specific affinity enrichment of electrochemically cleaved peptides based on Cu (II)-mediated spirolactone tagging | |
| US20160200777A1 (en) | Methionyl trna synthetase for biosynthesis of photomethionine-labeled protein and method for preparing photoactive protein g variant using same | |
| Fukuoka et al. | Hyperpolarization Modulation of the T‐Type hCav3. 2 Channel by Human Synenkephalin [1–53], a Shrew Neurotoxin Analogue without Paralytic Effects |